Verwandte Artikel zu The effectiveness of RIA therapy Cancer thyroid Doses...

The effectiveness of RIA therapy Cancer thyroid Doses 30 mCi , 50 mCi: Internal Dosemetry in RIA therapy for low risk cancer thyroid - Softcover

Benabdessadok, Abdelhadi; Badraoui, Manal; Otmane, Raja

 
9786209264450: The effectiveness of RIA therapy Cancer thyroid Doses 30 mCi , 50 mCi: Internal Dosemetry in RIA therapy for low risk cancer thyroid

Inhaltsangabe

RIA therapy is crucial for treating thyroid disorders, specifically thyroid cancer. This study aims to evaluate the efficacy of 30 mCi and 50 mCi RIA therapy doses in low-risk papillary thyroid carcinoma patients post-thyroidectomy, based on their thyroglobulin levels. In order to achieve this goal, we have carefully analyzed and evaluated the thyroglobulin levels before and after radioiodine treatment while also examining the values from different viewpoints. In our thorough analysis, we found that about 90% of study participants experienced positive outcomes, indicating a high success rate. The study shows that both RIA therapy doses effectively reduced thyroglobulin levels in low-risk papillary thyroid carcinoma patients post-thyroidectomy. This provides insights into the optimal therapy dosage for this patient group. This approach should take into consideration the differences between patients, such as absorption rate and the specific state of the patient, in order to ensure a balance between therapeutic efficacy and radioexposure.

Die Inhaltsangabe kann sich auf eine andere Ausgabe dieses Titels beziehen.

Über die Autorin bzw. den Autor

I am Dr. Benabdessadok Abdelhadi, a medical physicist specializing in nuclear medicine. I possess the necessary qualifications, scientific and practical experience, and a strong scientific and research interest in the field of dosimetry in nuclear medicine; examples include PET scans, SPECT, theragnostics, RIA therapy, and thyroid scans.

„Über diesen Titel“ kann sich auf eine andere Ausgabe dieses Titels beziehen.